Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences